Mucormycosis: A rare fungal infection in tornado victims

Journal of Burn Care and Research

Volumn 35, Issue 3, 2014, Pages

  Austin, Cindy L ^a   Finley, Phillip J ^a   Mikkelson, Debbie R ^a   Tibbs, Brian ^a  

^a Mercy Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CLINDAMYCIN; DEXAMETHASONE; ERTAPENEM; HYDROCORTISONE; METRONIDAZOLE; NYSTATIN; ORGANIC MATTER; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; SOIL ORGANIC MATTER; TIGECYCLINE; VANCOMYCIN; ANTIFUNGAL AGENT;

ACUTE RESPIRATORY FAILURE; ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; AGED; ANTIBIOTIC THERAPY; APOPHYSOMYCES TRAPEZIFORMIS; ARTICLE; CANDIDA GLABRATA; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEBRIDEMENT; DIET THERAPY; ESCHERICHIA COLI; FEMALE; FUNGUS; FUNGUS CULTURE; HUMAN; INJURY; MALE; MIDDLE AGED; MUCORMYCOSIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SPLIT THICKNESS SKIN GRAFT; TORNADO; TREATMENT OUTCOME; ZYGOMYCETES; AGE; DISASTER VICTIM; EPIDEMIOLOGY; FOLLOW UP; IMMUNOCOMPETENCE; INJURY SCALE; MICROBIOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE TRAUMA; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SOFT TISSUE INJURIES; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES; WOUND INFECTION;

ADOLESCENT; AGE FACTORS; AGED; ANTIFUNGAL AGENTS; COMBINED MODALITY THERAPY; DEBRIDEMENT; DISASTER VICTIMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPETENCE; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; MISSOURI; MUCORMYCOSIS; MULTIPLE TRAUMA; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOFT TISSUE INJURIES; SURVIVAL RATE; TORNADOES; TREATMENT OUTCOME; WOUND INFECTION;

EID: 84900521052     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e318299d4bb     Document Type: Article

References (47)

1. Cocanour CS, Miller-Crotchett P, Reed RL 2nd, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992;32:12-5.
2. Center for Disease Control and Prevention. Mucormycosis (Zygomycosis) 2012; available from http://www.cdc.gov/ fungal/mucormycosis/.
3. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634-53. (Pubitemid 41170352)
4. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994;19:67-76. (Pubitemid 24227037)
5. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 2011;24:411-45.
6. Cox GM. Mucormycosis (Zygomycosis) 2012; available from http://www.uptodate.com/contents/mucormycosis-zygomycosis.
7. Andresen D, Donaldson A, Choo L, et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 2005;365:876-8. (Pubitemid 40332166)
8. Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol 2005;129:569-82. (Pubitemid 40825818)
9. Nagy-Agren SE, Chu P, Smith GJ, Waskin HA, Altice FL. Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:441-9.
10. Azhar A, Calubiran O, Kilaru RM, et al. Patient with abdominal pain-concealing gastrointestinal mucormycosis. Gastroenterol & Hepat 2009;5(9):657-61.
11. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18:556-69. (Pubitemid 40995116)
12. Ivers LC, Ryan ET. Infectious diseases of severe weatherrelated and flood-related natural disasters. Curr Opin Infect Dis 2006;19:408-14. (Pubitemid 44338098)
13. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301. (Pubitemid 30205427)
14. Etienne KA, Gillece J, Hilsabeck R, et al. Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011. PLoS One 2012;7(11):e49989.
15. Tilak R, Raina P, Gupta SK, Tilak V, Prakash P, Gulati AK. Cutaneous zygomycosis: a possible postoperative complication in immunocompetent individuals. Indian J Dermatol Venereol Leprol 2009;75:596-9.
16. Evriviades D, Jeffery S, Cubison T, et al. Shaping the military wound: issues surrounding the reconstruction of injured servicemen at the Royal Centre for Defense Medicine. Phil Trans R Soc B 2011; 366: 219-30.
17. Ayala-Gaytán JJ, Petersen-Morfín S, Guajardo-Lara CE, Barbosa-Quintana A, Morfín-Otero R, Rodriguez-Noriega E. Cutaneous zygomycosis in immunocompetent patients in Mexico. Mycoses 2010;53:538-40.
18. D'Avignon LC, Chung KK, Saffle JR, Renz EM, Cancio LC; Prevention of Combat-Related Infections Guidelines Panel. Prevention of infections associated with combatrelated burn injuries. J Trauma 2011;71(2 Suppl 2): S282-9.
19. Ramasamy A, Hill AM, Clasper JC. Improvised explosive devices: pathophysiology, injury profiles and current medical management. J R Army Med Corps 2009;155:265-72.
20. Hospenthal DR, Chung KK, Lairet K, et al. Saksenaea erythrospora infection following combat trauma. J Clin Microbiol 2011;49:3707-9.
21. Tully CC, Romanelli AM, Sutton DA, Wickes BL, Hospenthal DR. Fatal Actinomucor elegans var. kuwaitiensis infection following combat trauma. J Clin Microbiol 2009;47:3394-9.
22. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006;20:581-607, vi. (Pubitemid 44375113)
23. Kontoyiannis DP, Lewis RE, Lortholary O, et al. Future directions in mucormycosis research. Clin Infect Dis 2012;54(Suppl 1):S79-85.
24. Kivivuori SM, Karikoski R, Koukila-Kahkola P, et al. Zygomycosis presenting a major clinical challenge: case report on Rhizomucor pusillus infections in a stemcell- transplant recipient. Mycopathologia 2011: 172: 241-45.
25. Waness A, Dawsari G, Jahdali H. The rise of an opportunistic infection called "Invasive Zygomycosis." J Global Infect Dis 2009; 1(2):131-38.
26. Sanz Alonso MA, Jarque Ramos I, Salavert Lleti M, et al. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clin Microbiol Infect Dis 2006; 12(Suppl 7):2-6. (Pubitemid 44756306)
27. Vazquez JA. Zygomycosis clinical presentation 2011; available from http://emedicine.medscape.com/article/ 232465-clinical
28. Weddle G, Gandy K, Bratcher D, Pahud B, Jackson MA. Apophysomyces trapeziformis infection associated with a tornado-related injury. Pediatr Infect Dis J 2012; 31:640-2.
29. Center for Disease Control and Prevention. Morbidity and mortality weekly report. Notes from the field: fatal fungal soft-tissue infections after a tornado, Joplin, MO, 2011; available from http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm6029a5.htm?s-cid+mm6029a5-e%od%oa
30. Perkhofer S, Locher M, Cuenca-Estrella M, et al. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob Agents Chemother 2008;52:2636-8. (Pubitemid 351915698)
31. Spellberg B, Walsh TJ, Kontoyiannis DP, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009;48:1743-51.
32. Schofield CM, Murray CK, Horvath EE, et al. Correlation of culture with histopathology in fungal burn wound colonization and infection. Burns 2007;33:341-6. (Pubitemid 46437357)
33. Fanfair RB, Benedict KB, Bos J, et al. Nectrotizing cutaneous Mucormycosis after a tornado in Joplin, MO, in 2011. N Engl J Med 2012; 367:2214-25.
34. Waness A, El-Sameed YA, Mahboub B, et al. Respiratory disorders in the Middle East: a review. Respirology 2011;16: 755-66.
35. Bray WH, Giangiacomo J, Ide CH. Orbital apex syndrome. Surv Ophthalmol 1987;32:136-40. (Pubitemid 18004777)
36. Ferguson AD. Rhinocerebral mucormycosis acquired after a short course of prednisone therapy. J Am Osteopath Assoc 2007;107:491-3. (Pubitemid 350224062)
37. MacLeod J. Skin-disease due to monila and other yeast-like fungi. British J Derm Syphilis 1930;552.
38. Sarabahi S, Tiwari VK, Arora S, Capoor MR, Pandey A. Changing pattern of fungal infection in burn patients. Burns 2012;38:520-8.
39. Baker CC. Immune mechanisms and host resistance in the trauma patient. Yale J Biol Med 1986;59:387-93. (Pubitemid 17187215)
40. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbial Infect 2000;15(Suppl 5): 41-5.
41. Boelaert JR, de Locht M, Van Cutsem J, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993;91:1979-86. (Pubitemid 23141469)
42. Spellberg B, Andes D, Perez M, et al. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother 2009;53:3122-5.
43. Daly AL, Velazquez LA, Bradley SF, Kauffman CA. Mucormycosis: association with deferoxamine therapy. Am J Med 1989;87:468-71. (Pubitemid 19247188)
44. Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The deferasirox- ambisome therapy for mucormycosis study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012; 67(3):715-22.
45. Horvath EE, Murray CK, Vaughan GM, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg 2007;245:978-85. (Pubitemid 46809301)
46. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis 2009;15:1395-401.
47. NOAA National Climatic Data Center, State of Climate: Tornadoes for Annual 2011, published online December 2011; available from http://www.ncdc. noaa.gov/sotc/tornadoes/ 2011/13; Internet; accessed 6 December 2012.